Aloe Vera and Cancer

Aloe Vera and Cancer

Aloe vera, a succulent plant species, has a long history in folk medicine. Its clear, viscous liquid has been used to treat skin problems and other disorders since ancient times. In the last century, oral consumption and the injection of aloe have also come to popular attention. Its topical use is effective in the treatment of burns and abrasions, and oral use is effective in the treatment of constipation. However, it has not been found to be superior to standard treatments. Most recently, claims of anti-cancer properties are prevalent. It has been found to inhibit proliferation and angiogenesis, and to induce apoptosis in cancer cells. Yet other clinical studies indicate that Aloe vera did not prevent or reduce the number of radiotherapy-related lesions; it merely delayed onset. Furthermore, many instances of toxicity and mortality have been reported in the literature. Today, it is better to avoid it, especially forms taken orally or by injection

___

  • 1. Farooqi AA, Sreeramu BS. Cultivation of medicinal and aromatic crops. Orient Longman, India. 2001.
  • 2. Reynolds T, Dweck AC. Aloe vera leaf gel: a review update. J Ethnopharmacol 1999;68(1-3):3–37.
  • 3. Foster M, Hunter D, Samman S. Evaluation of the nutritional and metabolic effects of Aloe vera. In: Benzie IFF, Wachtel-Galor S, editors. Source herbal medicine: biomolecular and clinical aspects. 2nd ed. Boca Raton (FL): CRC Press/Taylor & Francis; 2011.
  • 4. Collins EE, Collins C. Roentgen dermatitis treated with fresh whole leaf of aloe vera. Am J Roentgenol 1935;33:396–7.
  • 5. Wright CS. Aloe vera in the treatment of roentgen ulcers and telangiectasis. J Am Med Assoc 1935;106:1363–4.
  • 6. Ernst E, Pittler MH, Wider B, Boddy K. The desktop guide to complementary and alternative medicine. 2nd ed. Edinburgh: Elsevier Mosby; 2006.
  • 7. Boudreau MD, Beland FA. An evaluation of the biological and toxicological properties of Aloe barbadensis (miller), Aloe vera. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2006;24(1):103–54.
  • 8. Hossain MS, Mamun-Or-Rashid ANM, Towfique NM, Sen MK. A review on ethnopharmacological potential of Aloe vera L. J Intercult Ethnopharmacol 2013;2:113–20.
  • 9. Serrano M, Valverde JM, Guillén F, Castillo S, Martínez-Romero D, Valero D. Use of Aloe vera gel coating preserves the functional properties of table grapes. J Agric Food Chem 2006;54(11):3882–6.
  • 10.National Center for Complementary and Alternative Medicine. “Aloe Vera – Side Effects and Cautions”. https://nccih.nih.gov/health/aloevera#cautions Retrieved 2011;10–7.
  • 11.Feily A, Namazi MR. Aloe vera in dermatology: a brief review. G Ital Dermatol Venereol 2009;144(1):85–91.
  • 12.Food and Drug Administration. Status of Certain Additional Over-the-Counter Drug Category II and III Active Ingredients. http://www.fda.gov/ohrms/ dockets/98fr/050902a.htm. Accessed November 26, 2014.
  • 13.Heggie S, Bryant GP, Tripcony L, Keller J, Rose P, Glendenning M, Heath J. A Phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue. Cancer Nurs 2002;25:442–51.
  • 14.Williams MS, Burk M, Loprinzi CL, Hill M, Schomberg PJ, Nearhood K, et al. Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys 1996;36(2):345–9.
  • 15.Richardson J, Smith JE, McIntyre M, Thomas R, Pilkington K. Aloe vera for preventing radiation-induced skin reactions: a systematic literature review. Clin Oncol (R Coll Radiol) 2005;17(6):478–84.
  • 16.George J. To assess the effectiveness of aloe vera gel in preventing skin reactions associated with radiotherapy. Indian Journal of Palliative Care 2011;17:91–103.
  • 17.Yagi A, Kabash A, Okamura N, Haraguchi H, Moustafa SM, Khalifa TI. Antioxidant, free radical scavenging and anti-inflammatory effects of aloesin derivatives in Aloe vera. Planta Med 2002;68(11):957–60.
  • 18.Pugh N, Ross SA, ElSohly MA, Pasco DS. Characterization of Aloeride, a new high-molecular-weight polysaccharide from Aloe vera with potent immunostimulatory activity. J Agric Food Chem 2001;49(2):1030–4.
  • 19.Lee KH, Kim JH, Lim DS, Kim CH. Anti-leukaemic and anti-mutagenic effects of di(2-ethylhexyl)phthalate isolated from Aloe vera Linne. J Pharm Pharmacol 2000;52(5):593–8.
  • 20.Lissoni P, Rovelli F, Brivio F, Zago R, Colciago M, Messina G, et al. A randomized study of chemotherapy versus biochemotherapy with chemotherapy plus Aloe arborescens in patients with metastatic cancer. In Vivo 2009;23(1):171–5.
  • 21.Shelton RM. Aloe vera. Its chemical and therapeutic properties. Int J Dermatol 1991;30(10):679–83.
  • 22.Luo J, Yuan Y, Chang P, Li D, Liu Z, Qu Y. Combination of aloe-emodin with radiation enhances radiation effects and improves differentiation in human cervical cancer cells. Mol Med Rep 2014;10(2):731–6.
  • 23.Kuo PL, Lin TC, Lin CC. The antiproliferative activity of aloe-emodin is through p53-dependent and p21- dependent apoptotic pathway in human hepatoma cell lines. Life Sci 2002;71(16):1879–92.
  • 24.Huang PH, Huang CY, Chen MC, Lee YT, Yue CH, Wang HY, et al. Emodin and Aloe-Emodin Sup press Breast Cancer Cell Proliferation through ER α Inhibition. Evid Based Complement Alternat Med 2013;2013:376123.
  • 25.Suboj P, Babykutty S, Srinivas P, Gopala S. Aloe emodin induces G2/M cell cycle arrest and apoptosis via activation of caspase-6 in human colon cancer cells. Pharmacology 2012;89(1-2):91–8.
  • 26.Lee HZ, Hsu SL, Liu MC, Wu CH. Effects and mechanisms of aloe-emodin on cell death in human lung squamous cell carcinoma. Eur J Pharmacol 2001;431(3):287–95.
  • 27.Chen HC, Hsieh WT, Chang WC, Chung JG. Aloeemodin induced in vitro G2/M arrest of cell cycle in human promyelocytic leukemia HL-60 cells. Food Chem Toxicol 2004;42(8):1251–7.
  • 28.Pecere T, Gazzola MV, Mucignat C, Parolin C, Vecchia FD, Cavaggioni A, et al. Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res 2000;60(11):2800–4.
  • 29.Pan Q, Pan H, Lou H, Xu Y, Tian L. Inhibition of the angiogenesis and growth of Aloin in human colorectal cancer in vitro and in vivo. Cancer Cell Int 2013;13(1):69.
  • 30.Yonehara A, Tanaka Y, Kulkeaw K, Era T, Nakanishi Y, Sugiyama D. Aloe vera Extract Suppresses Proliferation of Neuroblastoma Cells In Vitro. Anticancer Res 2015;35(8):4479–85.
  • 31.Liu K, Park C, Li S, Lee KW, Liu H, He L, et al. Aloeemodin suppresses prostate cancer by targeting the mTOR complex 2. Carcinogenesis 2012;33(7):1406–11.
  • 32.Ulbricht C, Armstrong J, Basch E, Basch S, Bent S, Dacey C, et al. An evidence-based systematic review of Aloe vera by the natural standard research collaboration. J Herb Pharmacother 2007;7(3-4):279–323.
  • 33.Sakai R. Epidemiologic survey on lung cancer with respect to cigarette smoking and plant diet. Jpn J Cancer Res 1989;80(6):513–20.
  • 34.Worthington HV, Clarkson JE, Bryan G, Furness S, Glenny AM, Littlewood A, et al. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 2011;(4):CD000978.
  • 35.Sudarshan R, Annigeri RG, Sree Vijayabala G. Aloe vera in the treatment for oral submucous fibrosis - a preliminary study. J Oral Pathol Med 2012;41(10):755– 61.
  • 36.Su CK, Mehta V, Ravikumar L, Shah R, Pinto H, Halpern J, et al. Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with headand-neck neoplasms. Int J Radiat Oncol Biol Phys 2004;60(1):171–7.
  • 37.Palmer ME, Haller C, McKinney PE, Klein-Schwartz W, Tschirgi A, Smolinske SC, et al. Adverse events associated with dietary supplements: an observational study. Lancet 2003;361(9352):101–6.
  • 38.Anonymous. MD Loses license after injecting aloe kills 3. Vol 20. Peabody, MA: National Council Against Health Fraud; 1997:4.
  • 39.Anonymous. License revoked for aloe vera use. Nat Med Law 1998;1:1–2.
  • 40.Pigatto PD, Guzzi G. Aloe linked to thyroid dysfunction. Arch Med Res 2005;36(5):608.
  • 41.Baretta Z, Ghiotto C, Marino D, Jirillo A. Aloe-induced hypokalemia in a patient with breast cancer during chemotherapy. Ann Oncol 2009;20(8):1445–6.
  • 42.Yang HN, Kim DJ, Kim YM, Kim BH, Sohn KM, Choi MJ, et al. Aloe-induced toxic hepatitis. J Korean Med Sci 2010;25(3):492–5.
  • 43.Rabe C, Musch A, Schirmacher P, Kruis W, Hoffmann R. Acute hepatitis induced by an Aloe vera preparation: a case report. World J Gastroenterol 2005;11(2):303–4.
  • 44.Lee J, Lee MS, Nam KW. Acute toxic hepatitis caused by an aloe vera preparation in a young patient: a case report with a literature review. Korean J Gastroenterol 2014;64(1):54–8.
  • 45.Schmidt JM, Greenspoon JS. Aloe vera dermal wound gel is associated with a delay in wound healing. Obstet Gynecol 1991;78(1):115–7.
  • 46.Kim EJ, Kim HJ, Kim SG, Lee YS, Oh JE, Seo JW, et al. Aloe-induced Henoch-Schonlein purpura. Nephrology (Carlton) 2007;12(1):109.
  • 47.Boudreau MD, Beland FA, Nichols JA, Pogribna M. Toxicology and carcinogenesis studies of a nondecolorized [corrected] whole leaf extract of Aloe barbadensis Miller (Aloe vera) in F344/N rats and B6C3F1 mice (drinking water study). Natl Toxicol Program Tech Rep Ser 2013;(577):1-266.
  • 48.Yokohira M, Matsuda Y, Suzuki S, Hosokawa K, Yamakawa K, Hashimoto N, et al. Equivocal colonic carcinogenicity of Aloe arborescens Miller var. natalensis berger at high-dose level in a Wistar Hannover rat 2-y study. J Food Sci 2009;74(2):T24–30.
  • 49.National Toxicology Program. Toxicology and carcinogenesis studies of 3,3’,4,4’-tetrachloroazobenzene (TCAB) (CAS No. 14047-09-7) in Harlan SpragueDawley rats and B6C3F1 mice (gavage studies). Natl Toxicol Program Tech Rep Ser 2010;(558):1–206.
  • 50.Djuv A, Nilsen OG. Aloe vera juice: IC₅₀ and dual mechanistic inhibition of CYP3A4 and CYP2D6. Phytother Res 2012;26(3):445–51.
  • 51.Lee A, Chui PT, Aun CS, Gin T, Lau AS. Possible interaction between sevoflurane and Aloe vera. Ann Pharmacother 2004;38(10):1651–4.